Identification of metabolic biomarkers and therapeutic targets in the thymoma-associated myasthenia gravis treated with methylprednisolone

Abstract Objective This study aims to screen and identify metabolic biomarkers and targets for methylprednisolone treatment of thymoma with myasthenia gravis (MG) through metabolomics and network pharmacology analysis, thereby improving guidance for clinical medication and treatment. Methods Serum f...

Descripción completa

Detalles Bibliográficos

Autores principales:	Shanshan Gu, Xu Wang, Hongxia Yang, Yaxuan Wang, Congya Yan, Xiaoting Lin, Peng Liu, Lu Liu, Li Meng, Guoyan Qi
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Springer 2025-05-01
Colección:	Discover Oncology
Materias:	Thymoma Myasthenia gravis Metabolomics LC–MS Network pharmacology
Acceso en línea:	https://doi.org/10.1007/s12672-025-02700-2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!